Interní Med. 2014; 16(3): 110-112

The influence of vitamin D on immune mechanisms

prof.MUDr.Ivan Šterzl, CSc.
Endokrinologický ústav, oddělení klinické imunoendokrinologie, Praha

Vitamin D plays a role in development and prevention of many pathological states. Immune system is involved in the whole organism,

maintains homeostasis, position of the individual in the environment and is one of the most important regulatory systems of the organisms

with incredible adaptation capability. In this review I am concerned with the influence of active vitamin D3 on the immune system,

especially in the scope of innate and adaptive immunity. Through the immune system vitamin D is important in defense against infections,

tumor diseases and in development of immunopathological reactions, especially in autoimmunity.

Keywords: vitamin D, innate immunity, adaptive immunity, autoimmunity, infections

Published: May 26, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šterzl I. The influence of vitamin D on immune mechanisms. Interní Med. 2014;16(3):110-112.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 2007; 66: 1137-1142. Go to original source... Go to PubMed...
    2. Linker-Israeli M, Elstner E, Klinenberg JR, et al. Vitamin D (3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin Immunol. 2001; 99: 82-93. Go to original source... Go to PubMed...
    3. Andjelkovic Z, Vojinovic J, Pejnovic N, et al. Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol. 1999; 17: 453-456. Go to PubMed...
    4. Hypponen E, Laara E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001; 358: 1500-1503. Go to original source... Go to PubMed...
    5. Blaney GP, Albert PJ, Proal AD. Vitamin D metabolites as clinical markers in autoimmune and chronic disease. Ann N Y Acad Sci. 2009; 1173: 384-390. Go to original source... Go to PubMed...
    6. Albert PJ, Proal AD, Marshall TG. Vitamin D: the alternative hypothesis. Autoimmun Rev. 2009; 8: 639-644. Go to original source... Go to PubMed...
    7. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am. 2010; 39: 365-379, table of contents. Go to original source... Go to PubMed...
    8. Sterzl I. [D vitamin and immunity]. Vnitr Lek. 2012, 58: 405-410. Go to PubMed...
    9. Šterzl I. Přehledná imunoendokrinologie. Praha: Maxdorf 2006.
    10. Mathieu C, Van Etten, E., Overbergh, L., Bouillon, R. Vitamin D3 in Control of Immune Response, In: Immunoendocrinology in Health and Disease, Geenen V, Chrousos, George, New York: Marcel Dekker 2006.
    11. Adams JS, Ren S, Liu PT, et al. Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol. 2009; 182: 4289-4295. Go to original source... Go to PubMed...
    12. Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood). 2004; 229: 1136-1142. Go to original source... Go to PubMed...
    13. Peric M, Koglin S, Kim SM, et al. IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J Immunol. 2008; 181: 8504-8512. Go to original source... Go to PubMed...
    14. Sadeghi K, Wessner B, Laggner U, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol. 2006; 36: 361-370. Go to original source... Go to PubMed...
    15. Hewison M, Freeman L, Hughes SV, et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol. 2003; 170: 5382-5390. Go to original source... Go to PubMed...
    16. Topilski I, Flaishon L, Naveh Y, et al. The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol. 2004; 34: 1068-1076. Go to original source... Go to PubMed...
    17. Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol. 2006; 18: 349-356. Go to original source... Go to PubMed...
    18. Barrat FJ, Cua DJ, Boonstra A, et al. In vitro generation of interleukin 10-producing regulatory CD4 (+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med. 2002; 195: 603-616. Go to original source... Go to PubMed...
    19. Urry Z, Xystrakis E, Richards DF, et al. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha, 25-dihydroxyvitamin D3 abrogates regulatory function. J Clin Invest. 2009; 119: 387-398. Go to original source...
    20. Sigmundsdottir H, Pan J, Debes GF, et al. DCs metabolize sunlight-induced vitamin D3 to, program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol. 2007; 8: 285-293. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.